Lidocaine (Versatis®)

Changes to the reimbursement of lidocaine medicated plasters (Versatis®) under the Community Drug Schemes were introduced in September 2017. 

Following these changes, a clinician must submit an online application for individual reimbursement approval for each patient. 

An online application is required to be submitted irrespective of the indication for treatment with lidocaine medicated plasters (Versatis®).

All clinicians (GPs and hospital prescribers), once user-registered with the HSE-Primary Care Reimbursement Service (PCRS), can apply for reimbursement of lidocaine medicated plasters (Versatis®).

Further information on lidocaine medicated plasters (Versatis®)